Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Walker

Showing results (301-310 of 342) with videos related to

Pageof 35
Sort By:
Cancer Research|October 19, 2007
A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activityDavid A Rider, Carin E G Havenith, Ruby de Ridder, et al.
Heart (British Cardiac Society)|August 21, 2020
Cost-effectiveness of cardiovascular imaging for stable coronary heart diseaseSimon Walker, Edward Cox, Ben Rothwell, et al.
Health Technology Assessment (Winchester, England)|December 7, 2016
The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trialSally Brabyn, Ricardo Araya, Michael Barkham, et al.
International Journal of Radiation Oncology, Biology, Physics|July 16, 2013
Evaluation and immunohistochemical qualification of carbogen-induced ΔR₂ as a noninvasive imaging biomarker of improved tumor oxygenationLauren C J Baker, Jessica K R Boult, Yann Jamin, et al.
Open Heart|May 2, 2023
Randomised trial of stable chest pain investigation: 3-year clinical and quality of life results from CE-MARC 2Colin C Everett, Colin Berry, Gerry P McCann, et al.
BMJ Open|May 19, 2025
Modelling diabetes and depression in Pakistan: using economic modelling to inform intervention design and a clinical trial of a behavioural activation interventionDavid Glynn, Pedro Saramago, Naveed Ahmed, et al.
Pilot and Feasibility Studies|February 3, 2026
Engagement of coMmunity through Participatory learning and action for cOntrol and preVEntion of Type 2 Diabetes and its Risk factors (EMPOWER-D): protocol for a feasibility cluster randomised controlled trial in urban PakistanSara Imtiaz, Rubia Zafar, Amber Tahir, et al.
Frontiers in Immunology|December 11, 2023
The Rac-GEF Tiam1 controls integrin-dependent neutrophil responsesKirsti Hornigold, Martin J Baker, Polly A Machin, et al.
Advances in Biological Regulation|November 25, 2015
Localizing the lipid products of PI3Kγ in neutrophilsLaura Norton, Yvonne Lindsay, Arnaud Deladeriere, et al.
Science Translational Medicine|October 22, 2025
Leucine-rich α-2-glycoprotein 1 initiates the onset of diabetic retinopathy in miceGiulia De Rossi, Ao-Wang Qiu, Maxime Berg, et al.
Pageof 35

Showing results (301-310 of 342) with videos related to

Sort By:
Pageof 35
Cancer Research|October 19, 2007
A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activityDavid A Rider, Carin E G Havenith, Ruby de Ridder, et al.
Heart (British Cardiac Society)|August 21, 2020
Cost-effectiveness of cardiovascular imaging for stable coronary heart diseaseSimon Walker, Edward Cox, Ben Rothwell, et al.
Health Technology Assessment (Winchester, England)|December 7, 2016
The second Randomised Evaluation of the Effectiveness, cost-effectiveness and Acceptability of Computerised Therapy (REEACT-2) trial: does the provision of telephone support enhance the effectiveness of computer-delivered cognitive behaviour therapy? A randomised controlled trialSally Brabyn, Ricardo Araya, Michael Barkham, et al.
International Journal of Radiation Oncology, Biology, Physics|July 16, 2013
Evaluation and immunohistochemical qualification of carbogen-induced ΔR₂ as a noninvasive imaging biomarker of improved tumor oxygenationLauren C J Baker, Jessica K R Boult, Yann Jamin, et al.
Open Heart|May 2, 2023
Randomised trial of stable chest pain investigation: 3-year clinical and quality of life results from CE-MARC 2Colin C Everett, Colin Berry, Gerry P McCann, et al.
BMJ Open|May 19, 2025
Modelling diabetes and depression in Pakistan: using economic modelling to inform intervention design and a clinical trial of a behavioural activation interventionDavid Glynn, Pedro Saramago, Naveed Ahmed, et al.
Pilot and Feasibility Studies|February 3, 2026
Engagement of coMmunity through Participatory learning and action for cOntrol and preVEntion of Type 2 Diabetes and its Risk factors (EMPOWER-D): protocol for a feasibility cluster randomised controlled trial in urban PakistanSara Imtiaz, Rubia Zafar, Amber Tahir, et al.
Frontiers in Immunology|December 11, 2023
The Rac-GEF Tiam1 controls integrin-dependent neutrophil responsesKirsti Hornigold, Martin J Baker, Polly A Machin, et al.
Advances in Biological Regulation|November 25, 2015
Localizing the lipid products of PI3Kγ in neutrophilsLaura Norton, Yvonne Lindsay, Arnaud Deladeriere, et al.
Science Translational Medicine|October 22, 2025
Leucine-rich α-2-glycoprotein 1 initiates the onset of diabetic retinopathy in miceGiulia De Rossi, Ao-Wang Qiu, Maxime Berg, et al.
Pageof 35